Stay updated on Daratumumab in High-Risk MGUS & Low-Risk Smoldering Clinical Trial
Sign up to get notified when there's something new on the Daratumumab in High-Risk MGUS & Low-Risk Smoldering Clinical Trial page.

Latest updates to the Daratumumab in High-Risk MGUS & Low-Risk Smoldering Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedResults have been posted for the study, with corresponding QC dates noted. A PDF of the Study Protocol and Statistical Analysis Plan has been added to Study Documents.SummaryDifference1%

- Check21 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0; the page now reflects the newer revision label.SummaryDifference0.1%

- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check49 days agoChange DetectedThe page now shows 'Results Submitted' in the Results section, replacing the previous 'No Results Posted' status.SummaryDifference0.1%

- Check57 days agoChange DetectedThe page revision label has been updated from v3.4.1 to v3.4.2, a minor update with no changes to the study data or display. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check64 days agoChange DetectedRevision: v3.4.1 replaces v3.4.0 as the site version. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Daratumumab in High-Risk MGUS & Low-Risk Smoldering Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Daratumumab in High-Risk MGUS & Low-Risk Smoldering Clinical Trial page.